[Skip to Navigation]
April 1996

Medical Treatment for Cysticercosis-Reply

Author Affiliations

Department of Neurology, Luis Vernaza Hospital, Guayaquil, Ecuador

Arch Neurol. 1996;53(4):295-296. doi:10.1001/archneur.1996.00550040021006

In reply  We would like to answer that the undue concerns of Garg and Agrawal are typical of those who are not familiar with the medical treatment of neurocysticercosis. As several different aspects were commented on in their letter, I would like to analyze them step by step.1. They stated that patients with epilepsy due to single viable cysticerci (hypodense cystic lesions) have not been reported. I would like to bring to their attention our article1 on epilepsy due to neurocysticercosis published more than 3 years ago. In that study, 30 (15%) of 203 patients had epilepsy caused by a single hypodense cystic lesion. In addition, several reports on drug therapy for parenchymal neurocysticercosis had included patients with single hypodense cystic lesions who presented with epilepsy as the primary or sole manifestation of the disease.2-52. Garg and Agrawal stated that "several" deaths have occurred as the result

Add or change institution